Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

(2012) M. Aapro et al.   ANNALS OF ONCOLOGY

An Exploratory Study to Clarify the Cluster of Symptoms Predictive of Chemotherapy-Related Nausea Using Random Forest Modeling

(2012) Alex Molassiotis et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice

(2010) Alexander Molassiotis et al.   SUPPORTIVE CARE IN CANCER

Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study

(2010) Carlo Pirri et al.   SUPPORTIVE CARE IN CANCER

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy

(2010) David G. Warr et al.   SUPPORTIVE CARE IN CANCER

Clinical Predictors of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide

(2009) Vivianne Shih et al.   ANNALS OF PHARMACOTHERAPY

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

(2009) Paul J. Hesketh et al.   SUPPORTIVE CARE IN CANCER

Understanding the concept of chemotherapy-related nausea: the patient experience

(2008) A. MOLASSIOTIS et al.   EUROPEAN JOURNAL OF CANCER CARE